$200K - 200K a year
Lead clinical development strategies and plans for neurology drug therapies across all phases, coordinate cross-functional teams, and engage with regulatory and scientific stakeholders.
Extensive executive leadership experience in clinical drug development, expertise in neurology indications, regulatory interactions, and cross-departmental project coordination.
This is a high impact position with great visibility across all levels of the Alkermes organization. The primary role is to drive Alkermes’s clinical development portfolio in Neurology. Specifically, this position will have critical hands-on leadership responsibilities within the Clinical department, focused on the development of therapies for Neurology and Neuropsychology indications—including, but not limited to, sleep disorders, neuropsych, and neurodegenerative diseases. The Vice President will drive the strategies and clinical plans across all phases of drug development. Key domains include development of study protocols, medical review of clinical trial data, and generation of clinical study reports. The Vice President will interact externally with key global regulatory authorities, industry and scientific organizations, as well as external key thought leaders. This position will work cross-functionally to ensure projects are coordinated with partners from multiple departments within Alkermes, including Regulatory, Preclinical Pharmacology and Toxicology, CMC, New Product Planning, Project Management, Patient Engagement, Health Economics, Legal, Finance, Medical Affairs, and Commercial.
This job posting was last updated on 10/10/2025